In TME, IL‐1β activating suppressor of mothers against decapentaplegic/DNA‐binding 1 protein inhibitor, the Smad/ID1 signaling pathway ensures maintenance of the stemness traits of melanoma cells, thus acting as a promoter of tumor relapse and metastasis. This evidence concerns the gene IL1B and neoplasm.